Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020

Abstract Despite the high cure rate with initial therapy, approximately 10% of Hodgkin lymphoma (HL) patients are refractory to initial treatment, and up to 30% of patients will relapse after achieving initial complete remission. Despite promising initial results of treatment by immune checkpoint in...

Full description

Bibliographic Details
Main Authors: Helena Simeunovic, Martina Dickenmann, Mitja Nabergoj, Helen Baldomero, Stavroula Masouridi‐Levrat, Gayathri Nair, Urs Schanz, Jacob Passweg, Alicia Rovo, Yves Chalandon, Ekaterina Rebmann
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:eJHaem
Subjects:
allogeneic stem cell transplantation
Hodgkin lymphoma
Online Access:https://doi.org/10.1002/jha2.629

Similar Items

Similar Items